NeuroOne® to Report First Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on February 13
February 08 2024 - 3:30PM
NeuroOne Medical Technologies Corporation (Nasdaq: NMTC)
("NeuroOne" or the "Company"), a medical technology company focused
on improving surgical care options and outcomes for patients
suffering from neurological disorders, will host a conference call
and webcast on February 13, 2024 at 4:30 PM Eastern Time to
discuss financial results for its first quarter of fiscal year 2024
ended December 31, 2023, and provide a corporate update.
Conference Call and Webcast
Information:
Tuesday, February 13, 2024 – 4:30 PM Eastern
Time
Participant Dial-In:888-506-0062 / +1 973-528-0011
Access Code: 540724
Live Webcast: Join here.
Phone Replay: 877-481-4010/ +1 919-882-2331Available through
February 27, 2024
Webcast
Replay: Available
for 12 months
About NeuroOne
NeuroOne Medical Technologies Corporation is a
developmental stage company committed to providing minimally
invasive and hi-definition solutions for EEG recording, brain
stimulation and ablation solutions for patients suffering from
epilepsy, Parkinson's disease, dystonia, essential tremors, chronic
pain due to failed back surgeries, and other related neurological
disorders that may improve patient outcomes and reduce procedural
costs. The Company may also pursue applications for other areas
such as depression, mood disorders, pain, incontinence, high blood
pressure, and artificial intelligence. For more information,
visit nmtc1.com.
Contact:
800-631-4030
ir@nmtc1.com
NeuroOne Medical Technol... (NASDAQ:NMTC)
Historical Stock Chart
From Apr 2024 to May 2024
NeuroOne Medical Technol... (NASDAQ:NMTC)
Historical Stock Chart
From May 2023 to May 2024